MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
346.18%
Quick Ratio
346.18%
Cash Ratio
67.87%
Debt to Asset Ratio
30.67%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Short-term marketable securities
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paidin capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
19,167
28,660
19,960
25,256
Short-term marketable securities
72,389
76,756
70,791
70,656
Accounts receivable, prepaid expenses and other current assets
6,209
4,814
5,565
4,680
Total current assets
97,765
110,230
96,316
100,592
Marketable securities
79,065
85,372
60,612
71,297
Property and equipment, net
664
750
761
811
Other assets
2,199
2,368
2,771
2,834
Total assets
179,693
198,720
160,460
175,534
Accounts payable
15,516
14,731
13,158
9,187
Accrued expenses
5,959
5,896
8,791
9,784
Deferred income
3,976
3,972
3,943
3,925
Other current liabilities
2,790
2,771
2,753
2,735
Total current liabilities
28,241
27,370
28,645
25,631
Other liabilities
1,262
1,416
1,565
1,711
Deferred income, net of current portion
14,309
15,285
16,168
17,492
Contingent consideration
11,300
11,000
11,000
10,600
Total liabilities
55,112
55,071
57,378
55,434
Common stock, 0.00001 par value 400,000,000 shares authorized at june 30, 2026 and december 31, 2025 139,824,273 and 120,499,433 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
1
1
1
1
Additional paidin capital
1,133,997
1,131,234
1,070,255
1,067,491
Accumulated other comprehensive (loss) income
-304
22
610
597
Accumulated deficit
-1,009,113
-987,608
-967,784
-947,989
Total stockholders' equity
124,581
143,649
103,082
120,100
Total liabilities and stockholders' equity
179,693
198,720
160,460
175,534
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$72,389K (-2.71%↓ Y/Y)Cash and cashequivalents$19,167K (-24.55%↓ Y/Y)Accounts receivable,prepaid expenses and...$6,209K Total current assets$97,765K (-6.18%↓ Y/Y)Marketable securities$79,065K (-2.49%↓ Y/Y)Other assets$2,199K (-26.53%↓ Y/Y)Property and equipment,net$664K (-23.50%↓ Y/Y)Total assets$179,693K (-5.00%↓ Y/Y)Total liabilities andstockholders' equity$179,693K (-5.00%↓ Y/Y)Total stockholders'equity$124,581K (-5.43%↓ Y/Y)Total liabilities$55,112K (-4.00%↓ Y/Y)Accumulated deficit-$1,009,113K (-8.11%↓ Y/Y)Accumulated othercomprehensive (loss) income-$304K (-163.07%↓ Y/Y)Additional paidin capital$1,133,997K (6.52%↑ Y/Y)Total currentliabilities$28,241K (5.22%↑ Y/Y)Deferred income, net ofcurrent portion$14,309K (-21.46%↓ Y/Y)Contingent consideration$11,300K (7.62%↑ Y/Y)Other liabilities$1,262K (-31.82%↓ Y/Y)Common stock, 0.00001par value...$1K (0.00%↑ Y/Y)Accounts payable$15,516K (76.38%↑ Y/Y)Accrued expenses$5,959K (-47.78%↓ Y/Y)Deferred income$3,976K (1.58%↑ Y/Y)Other currentliabilities$2,790K (2.69%↑ Y/Y)

Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics, Inc. (ACRS)